News search

    E.g., 23/11/2024
    E.g., 23/11/2024
    About the CNIC
    15 May 2024
    CNIC Co-Leads REACT, an international precision medicine project to transform cardiovascular prevention

    Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total
    Alexandra y Xoel
    About the CNIC
    11 May 2024
    CNIC receives a donation to investigate Hutchinson–Gilford progeria syndrome
    De izquierda a derecha: Immunofluorescencia en sección de corazón de pez cebra tras criolesion mostrando células proliferativas (blanco), cardiomiocitos (rojo) núcleos celulares (azul). Imagen de Microscopia electrónica mostrando mitocondrias. Gel Blue Native mostrando bandas correspondientes a supercomplejos formados por CIII (rojo) y CIV (verde).
    Research
    6 May 2024
    Development Cell: A CNIC study reveals the key role of mitochondrial proteins in cardiac regeneration

    Scientists at the CNIC, CIBER, and University of Berne identify the fundamental role of a family of proteins in an essential process for cellular energy production
    María Jesús Andrés, Carla Espinós (detrás), Rosa M Nevado (delante, al lado de MJA), Miguel de la Fuente, Rosa Carmona, Ana Barettino, Vicente Andrés, Pilar Gonzalo e Ignacio Benedicto.
    Research
    19 Apr 2024
    PNAS: CNIC scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome

    The elimination of progerin from vascular smooth muscle cells, but not from endothelial cells, prevents the atherosclerosis associated with Hutchinson-Gilford progeria syndrome (HGPS)
    RM cardiaca de un paciente con miocardiopatía dilatada (izquierda) y de un individuo sin cardiopatía (derecha). En el paciente con miocardiopatía dilatada el tamaño del corazón esta incrementado y su capacidad de bombeo está disminuida.
    Research
    19 Apr 2024
    JACC: A new Spanish study provides the first stratification of the risk of developing dilated cardiomyopathy among symptom-free genetic carriers

    The results, published in JACC, suggest that these factors could be used to predict the risk of developing dilated cardiomyopathy and adapt strategies for patient care and disease detection in genetic carriers of the disease

    Agustín Clemente-Moragón, Borja Ibáñez, Anabel Díaz-Guerra, Laura Cádiz, Carlos Galán-Arriola, Miguel Fernández-Tocino, Mónica Gómez, Rocío Villena-Gutiérrez, y Eduardo Oliver.
    Research
    16 Apr 2024
    JACC: CardioOncology: CNIC scientists identify therapeutic targets for the prevention of heart injury linked to cancer treatment

    The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxicity
    Vicente Andrés, director de investigación básica del CNIC; Dr. Valentín Fuster, director general del CNIC; Dra. del Instituto de Salud Carlos III, Dra. Marina Pollán; Alberto Sanz, director gerente del CNIC; el Dr. Borja Ibáñez, director científico y director de investigación clínica del CNIC; D. Agustín González, subdirector general de redes y centros de investigación cooperativa del Instituto de Salud Carlos III., e Icíar Areilza, secretaria general de la Fundación Pro CNIC.
    About the CNIC
    12 Apr 2024
    Visit of the Director of Carlos III Health Institute, Dr Marina Pollán, to CNIC
    Miembros del equipo del Dr. Miguel Torres.
    About the CNIC
    11 Apr 2024
    The REACTIVA project, led by CNIC scientist Dr. Miguel Torres, receives ERC Advanced Grant funding

    The CNIC project will use innovative approaches to investigate cardiac regeneration

    María Linarejos Vera, Gema Mondéjar, Amaia Talavera, Patricia Sánchez, Álvaro Macías, Juan Manuel Ruiz, Francisco M. Cruz, Fernando Martínez de Benito, Juan Antonio Bernal y José Jalife
    Research
    11 Apr 2024
    Circulation Research: New mechanism discovered for the life-threatening arrhythmias in Andersen-Tawil syndrome

    CNIC researchers, led by Dr. José Jalife, have made a key discovery about cardiac arrhythmias in Andersen-Tawil syndrome (ATS)
    El Dr. Valentín Fuster con la Dra. Guiomar Mendieta
    About the CNIC
    10 Apr 2024
    The Journal of the American College of Cardiology garlands the CNIC author of a PESA-CNIC-SANTANDER study

    Guiomar Mendieta has been awarded the 2023 William W. Parmley Young Author Achievement Award for a paper published in JACC that is considered to an outstanding contribution in the field of atherosclerosis